We aimed to confirm the reliability of the Japanese version of the Aging Males' Symptoms rating scale (JPN-AMS) and its applicability in patients with testosterone deficiency syndrome (TDS)-like symptoms, comparing it for young, middle-aged and elderly Japanese men. The study included 93 patients with TDS-like symptoms, 39 men younger than 30 years old, and 125 normal men 40 years old and older, who agreed to respond to a self-administered questionnaire using the JPN-AMS. Testing-retesting was done to confirm the reliability of the questionnaire, with a 2-week interval between tests. The total AMS score and three domain scores were clearly higher in patients with TDS-like symptoms than in young men and in normal males, respectively. The test-retest analysis showed good reliability and internal consistency for the JPN-AMS. The JPN-AMS can be reliably used for measuring health-related quality of life of aging Japanese males.
Introduction
Testosterone deficiency syndrome (TDS) has become a health issue for men throughout the world. TDS is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms and a deficiency in serum testosterone levels. 1, 2 Several questionnaires have been proposed for assessing the typical symptoms. [3] [4] [5] The Aging Males' Symptoms rating scale (AMS) is a useful tool for measuring the severity of symptoms related to aging, including three subdomains (psychological, somatic and sexual), and their impact on health-related quality of life. 5, 6 The AMS was originally developed in Germany. It has been well accepted internationally and distributed in many countries. 7, 8 A Japanese version of the Aging Males' Symptoms rating scale (JPN-AMS) was linguistically validated by the recommended six steps of the translation process: forward translations by at least two independent translators, a consensus meeting with the coordinator of the translation, a check by a bilingual expert in the application field of the scale to evaluate the scientific correctness of the wording, a backward translation, a consensus meeting among the translators with the coordinator and finally a pretest with a few persons for whom the test was designed. 6 However, its reliability and applicability for Japanese men were not fully confirmed.
In this context, we confirmed the reliability of the JPN-AMS and its applicability to Japanese men and patients with TDS.
Materials and methods
The JPN-AMS was downloaded from a website (http://www.aging-males-symptoms-scale. info/documents/AMS_Jap_final.pdf) and used for clinical study.
The study included 93 patients with TDS-like symptoms, 39 men younger than 30 years old and 125 normal men who were 40 years old and older. Patients were diagnosed as having TDS-like symptoms irrespective of the serum testosterone level when they visited a TDS clinic with complaints of such symptoms. The young men were medical students of Sapporo Medical University School of Medicine who were healthy and agreed to participate in the study. The normal men were healthy volunteers among those who received annual health examinations at the Hokkaido Social Insurance Hospital. They were examined and found to have no clinically apparent diseases that needed any treatments. We asked all of them to fill in the JPN-AMS and checked the serum total testosterone (TT) level for patients with TDS-like symptoms.
Results are expressed as the median and were considered to be statistically significant if the significance level reached o0.05. The Mann-Whitney U-test was used to determine differences in the distribution of responses to questionnaires for the two groups. In the TDS-like symptom group, we assessed the AMS score distribution related to TT. On the basis of TT, we divided this group into three subgroups: TT above 3.46 ng ml
À1
, TT between 3.46 and 2.31 ng ml À1 and TT below 2.31 ng ml
. 1 Serum samples were obtained between 0900 and 1100 hours. We used TT measured by Electro Chemiluminescence immunoassay in this study.
The internal consistency of the total score and the three domains of scores were calculated with Cronbach's alpha coefficient. 9 Twenty-three patients with TDS-like symptoms were randomly selected to take part in the test-retest reliability study. We asked the patients with TDS-like symptoms who visited our clinic during a given period and were born in an odd-numbered month to take part in the test-retest study. Of the 54 patients who visited our clinic during the period, 25 were born in an oddnumbered month. Two of the 25 patients refused to take part in the test-retest study. The differences in total scores and subdomains, and intraclass correlation coefficients between test and retest scores were computed. 10 Statistical analyses were performed using StatView 5.0 for Windows (SAS Institute, Cary, NC, USA) and SPSS v. 15 
Results
Participants' characteristics are shown in Table 1 . The young men were aged from 18 to 29 years. No difference of age distribution was found between patients with TDS-like symptoms and normal men.
Comparative study of AMS score The median of the total AMS score in the TDS-like symptoms group was 52, with scores ranging from 30 to 73 (Figure 1 ). The score was significantly higher than those in the group of young men (median total score: 24; range: 17-56; Po0.001 by the Mann-Whitney U-test) and in normal men (median total score: 31; range: 18-68; Po0.001 by the test). The score for each subdomain in the TDSlike symptom group was also higher than those in the groups of young men and normal men (Po0.001 for both by the test) (Figure 1) .
Of the 93 patients with TDS-like symptoms, 56 (60.2%) had severe symptoms defined by a total score greater than 50, and 32 (34.4%) had moderate symptoms with scores between 37 and 49. For comparison, 25.6% of normal aging men had severe or moderate symptoms and only one young adult had severe symptoms. 
Reliability of Japanese version of AMS K Kobayashi et al
The scores for the psychological, somatic and sexual domains were also higher in the TDS-like symptoms group than in the groups of young adults and normal aging men. Each score was very low in young adults and was slightly higher in aging men than in young adults.
TT in the TDS-like symptom group
Fifteen of the 93 patients with TDS-like symptoms (16.1%) had TT below 2.31 ng ml À1 , 30/93 patients (32.3%) had TT between 3.46 and 2.31 ng ml À1 and 48/93 (51.6%) had TT above 3.46 ng ml À1 . The AMS score of the group with TT below 2.31 ng ml À1 (median total score: 48; range: 30-63) was not significantly higher than that in the group with TT between 3.46 and 2.31 ng ml À1 (median total score: 50; range: 30-73; P ¼ 0.65 by the Mann-Whitney U-test) or that in the group with TT above 3.46 ng ml À1 (median total score: 55; range: 34-72; P ¼ 0.06 by the Mann-Whitney U-test) (Figure 2 ).
Reliability study
Cronbach's alpha coefficient, an indicator of the internal consistency of the scale, was more than 0.8 for the total score and each domain, showing the good internal consistency of the JPN-AMS on the basis of all the 257 participants ( Table 2 ). On the basis of each group, the alpha coefficient was more than 0.7 for the total and each domain.
Of 23 randomly selected patients with TDS-like symptoms who were asked to participate in the testretest study, 20 (87.0%) finally responded to our request. The reason for excluding three patients was an incomplete answer on the retest. Table 3 shows the distributions of total scores and scores for the three domains. These results suggested that they were also similar in the test and retest. Intraclass correlation coefficients for the results of the two tests ranged from 0.73 to 0.90.
Discussion
The AMS scale is internationally used for evaluating patients with TDS. 8 Linguistic validation for the Japanese language version was completed according to the international methodological recommendations. However, the Japanese translation was not evaluated by reliability analysis. In this study, we confirmed the reliability of the JPN-AMS. A previous report indicated that the internal consistency coefficients of the versions in various countries fell between 0.7 and 0.9 and that the test-retest coefficients of the total AMS score ranged between Figure 1 The distributions of the total AMS and three domain scores among the three groups. w denotes significantly different from young men by the Mann-Whitney U-test (Po0.001). z denotes significantly different from normal men by the MannWhitney U-test (Po0.001). Figure 2 The distribution of the total AMS related to serum total testosterone level. TT, serum total testosterone (ng ml À1 ). Reliability of Japanese version of AMS K Kobayashi et al 0.8 and 0.9. 8 We found the JPN-AMS to be equally reliable in a Japanese population.
Some test-retest coefficients of the three subscales were lower in some countries in Europe and Asia. 8 For example, the coefficients of the psychological scale were 0.50 and 0.54 in Spain and Italy, respectively. With regard to Asian countries, the coefficient of sexual scale was 0.68 in Thailand. In our study, the test-retest coefficients of the three subscales ranged between 0.73 and 0.90. Compared with other countries, there were good correlations among the subscales in this study.
Young men had much lower scores than normal men with or without TDS symptoms in Japan. The mean values of the AMS total scores also increased with age in a French study, 11 which was comparable with our results. In normal French men who were 40 years old and older, the mean score of total AMS was 30. 1, 12 which is also comparable with our result. As the AMS score was developed for measuring health-related quality of life and symptoms of aging males, our results indicate that the JPN-AMS can measure symptoms of aging Japanese males.
Although the JPN-AMS is very useful for measuring the severity of symptoms related to aging in many translations, it may not be an appropriate instrument for screening TDS in urological practice. Because the diagnosis of TDS needs to be confirmed by the decline of serum testosterone levels, 1 we should not diagnose patients as having TDS using only the AMS. It was reported that significant numbers of patients with undiagnosed major depressive disorder visited a TDS clinic. 13 Those patients had significantly higher total AMS scores than TDS patients and non-major depressive disorder men with normal testosterone. We should seriously consider that TDS is a clinical and biochemical syndrome associated with advancing age and characterized by typical symptoms and a deficiency in serum testosterone levels. Thus, it is important to understand that the AMS is not only a diagnostic tool, but primarily an health-related quality of life scale. 14 Another questionnaire for assessing TDS has the same problems. The Saint Louis University Androgen Deficiency of the Aging Male Questionnaire 3 is one of the useful tools to facilitate clinical diagnosis. However, a previous report evaluating the predictive capacity of the Saint Louis University Androgen Deficiency of the Aging Male questionnaire with regard to biochemical hypogonadism in the aging male reported that the questionnaire was a valid test to detect hypogonadism but had low specificity. 15 When we diagnose aging males as having TDS by using any questionnaire, evaluation of the biological findings such as testosterone levels is also crucial.
The AMS is widely used for measuring the symptoms of aging males in Japan. Some reports using the JPN-AMS have already been published. 13, 16, 17 The JPN-AMS will be used more widely in Japan because we confirmed its reliability and applicability in this study.
This study had some limitations. One of these was that the sample size for test-retest analysis was small. However, the sample size was sometimes small in measuring reliability in other countries as well. For example, the number of participants in test-retest analysis of AMS was 20, 20, 20 and 25 in Portugal, Italy, Thailand and Korea, respectively. 8 Therefore, we think that our results are similar to those of other countries in terms of a pilot study.
